Primazol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Primazol

Property Description
Active ingredient Sulfamethoxazole and Trimethoprim
Form Oral tablet, Oral suspension, Intravenous solution
Pharmacological class Antibacterials (Synergistic Antibacterial Agent)
Common use Antimicrobial prophylaxis and treatment
Origin Synthetic (Chemically manufactured)

What is Primazol and What Type of Medicine is It?

Primazol is a prescription-only medicine whose generic identity is Co-trimoxazole, a term utilized for this fixed-dose combination antibiotic. The drug is entirely synthetic and belongs to the broad class of Antibacterials. It is used for antimicrobial prophylaxis and treatment where clinically indicated. As a widely utilized combination, the formulation is often marketed under various global brand names, such as Septra and Bactrim, reflecting its established therapeutic role.


The Composition of Primazol: A Fixed-Dose Synergistic Agent

The active components in Primazol are Sulfamethoxazole, a sulfonamide antibiotic, and Trimethoprim, a diaminopyrimidine antibiotic. The preparation is defined as a fixed-dose combination because the two agents work together to act as a synergistic antibacterial agent, where the combined effect is enhanced compared to the individual components. This combination is fundamental to disrupting the bacteria’s ability to utilize a crucial nutrient, folate.


How This Dual Mechanism Serves a General Therapeutic Purpose

The fundamental purpose of Primazol’s unique dual mechanism is to achieve a bactericidal action against susceptible pathogens. The combined action, known as sequential enzyme blockade, interferes with the bacteria's ability to maintain and reproduce its essential genetic material. This mechanism is utilized for addressing infectious diseases, providing a method for pathogen elimination in typical use scenarios involving bacterial infections.

What side effects are possible with Primazol?

Possible Side Effects and Safety Information

The safety profile of Primazol (Co-trimoxazole) is systematically classified by regulatory authorities, grouping possible effects by body system and frequency. Understanding these documented risks is essential to grasping the medicine's risk profile.


Adverse Reaction Classification

Frequency Classification Examples (Organ Systems Affected)
Common (1% to <10%) Nausea, diarrhea, headache, general skin rash, and hyperkalemia (Metabolism and Nutrition Disorders).
Very Rare (<0.01%) Severe blood disorders (Agranulocytosis), severe cutaneous reactions (e.g., Stevens-Johnson Syndrome (SJS)), and Fulminant Hepatic Necrosis.

Serious Adverse Reactions

Official labeling emphasizes the risk of very rare but life-threatening events. These include Severe Cutaneous Adverse Reactions (SCARs) such as SJS and Toxic Epidermal Necrolysis (TEN), and severe blood dyscrasias like Aplastic Anemia. Serious reactions affecting the liver, such as Fulminant Hepatic Necrosis, and the lungs, such as Acute Respiratory Distress Syndrome (ARDS), are also documented.


Safety Considerations and Restrictions

Regulatory documents highlight safety constraints based on patient characteristics and exposure timing. Primazol is generally contraindicated in infants under two months of age and in individuals with severe hepatic parenchymal damage or severe renal insufficiency. Older adults are cited as being more susceptible to adverse reactions. The highest risk for severe skin reactions like SJS/TEN is generally documented within the first weeks of treatment. For long-term use, regular blood counts are officially advisable to monitor for asymptomatic changes.

Overdose and Emergency Response

Officially documented information regarding Primazol (Co-trimoxazole) overdose describes a range of manifestations and mandatory emergency responses as listed in regulatory documents.

Documented Manifestations and Severe Outcomes

Acute overexposure is officially associated with symptoms such as nausea, vomiting, dizziness, fever, and confusion. More serious outcomes resulting from acute or chronic high-dose toxicity include life-threatening conditions like Severe Cutaneous Adverse Reactions (SCARs), notably Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as fulminant hepatic necrosis. Overdose risks include specific laboratory abnormalities such as hyperkalaemia (high blood potassium) and the development of crystalluria or hematuria in the urinary tract. Chronic exposure may lead to bone marrow depression and megaloblastic anemia.

Mandatory Emergency Action

In the event of a suspected overdose, regulatory guidance mandates that individuals seek immediate medical attention or contact the Poison Help line. The medication must be stopped immediately if initial signs of severe reactions, such as a spreading rash, develop. Immediate medical care is required for life-threatening symptoms, including seizures or loss of consciousness.

Official Management Notes

Management is described as symptomatic and supportive treatment. Folinic acid (leucovorin) is documented for use in counteracting the trimethoprim component's toxicity on the bone marrow. The official profile notes that haemodialysis has limited efficacy. Elderly patients and individuals with impaired renal function are cited as being at increased risk of severe toxicity and accumulation.

Therapeutic Uses of Primazol

What Primazol Treats: Main Uses and Benefits

Primazol (Co-trimoxazole) is a combination antibacterial medication that is applied in addressing various infections caused by susceptible bacteria and protozoa. The drug is commonly used across therapeutic domains and conditions presenting with acute episodes. This medicine generally helps with groups of symptoms that may appear suddenly or intensify over time, providing support that helps ease the overall symptom burden.

Treating Acute Genitourinary and Gastrointestinal Symptom Clusters

This medication is relevant for easing symptoms related to conditions presenting with acute or disruptive episodes, including bacterial urinary tract infections (UTIs), acute exacerbations of chronic bronchitis, shigellosis, and certain cases of acute otitis media. In settings marked by temporary physiological imbalance, it supports the management of pronounced discomfort.

Managing Serious Opportunistic Infections and Prophylaxis

Primazol is also considered relevant for managing serious infections such as Pneumocystis jirovecii pneumonia (PJP/PCP). It is applied during phases of increased distress or discomfort for treatment or prophylaxis in immunocompromised individuals. This helps maintain a sense of stability and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Acute Symptomatic Manifestations Primazol is commonly used across domains where short-term symptomatic assistance is needed, providing supportive relief when symptoms interfere with routine activities.

Eligibility and Restrictions for Use

Who can and cannot use Primazol?

Primazol (Co-trimoxazole) eligibility is strictly defined by regulatory authorities and based on patient age, organ function, and specific pre-existing conditions.

Populations for Whom Use is Contraindicated

Use of Primazol is absolutely contraindicated in several groups, including patients with:

  • Known hypersensitivity to trimethoprim or sulfonamide derivatives.
  • Documented megaloblastic anemia due to folate deficiency.
  • Infants less than 2 months of age (due to the risk of kernicterus).
  • Marked hepatic damage or severe, unmonitored renal insufficiency (creatinine clearance less than 15 mL/minute).
  • Acute porphyria or a history of drug-induced immune thrombocytopenia.

Eligibility by Age and Physiological Status

Category Regulatory Status
Pediatric Use Approved for children 2 months of age and older.
Older Adults Eligible, but use is advised with particular care.
Pregnancy/Lactation Contraindicated in pregnant patients at term and in nursing mothers (risk of kernicterus).

Eligibility-Related Restrictions

Patients with moderate renal impairment (CrCl 15 to 30 mL/minute) are eligible only under a restricted-use protocol, which requires a dose reduction. Use in patients with G6PD deficiency is advised with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Primazol (a hypothetical sulfonamide/trimethoprim combination) is documented in regulatory labeling and involves several classes of co-administered medications, primarily through pharmacokinetic and pharmacodynamic mechanisms.


Documented Interaction Categories

Category Interacting Agents (Examples) Resulting Constraint/Effect
Contraindicated Clozapine Forbidden due to risk of severe hematological toxicity.
Pharmacokinetic Warfarin, Phenytoin, Digoxin Increased plasma concentration and exposure of the co-administered drug, requiring strict monitoring.
Pharmacodynamic ACE Inhibitors, Diuretics (Thiazides/K-Sparing) Increased risk of hyperkalaemia or thrombocytopenia (especially in the elderly).
Renal Transport Lamivudine, Procainamide Increased plasma levels of the co-administered drug due to competitive inhibition of renal tubular secretion.

Official Regulatory Statements

Official labeling requires close monitoring when Primazol is co-administered with certain drugs. For example, co-administration with Warfarin mandates frequent checks of INR/Prothrombin Time due to the potential for increased anticoagulant effects. Similarly, combining Primazol with medications like Methotrexate or Zidovudine is associated with an increased risk of bone marrow suppression and requires caution. The drug's effect on drug metabolism and transport systems means that specific agents, such as the anti-diabetic Repaglinide, may have their exposure significantly altered.

Mechanism of Action

Dual-Targeted Inhibition of Bacterial Folate Synthesis

The core action of Primazol is the sequential enzyme blockade of the bacterial folic acid synthesis pathway. The two active ingredients target different, consecutive steps: Sulfamethoxazole competitively inhibits dihydropteroate synthase (DHPS), while Trimethoprim inhibits dihydrofolate reductase (DHFR). This strategic two-pronged interference relies on the fact that bacteria must synthesize their own folate, in contrast to human cells which absorb it exogenously.


The Synergistic Mechanism and Nucleic Acid Disruption

This sequential blockade ensures that the combined action results in a mechanism that is bactericidal (microbe-killing), representing a change from the effect of the individual agents, which are typically only bacteriostatic (growth-inhibiting). The dual mechanism starves the pathogen of the essential cofactor, tetrahydrofolic acid (THF), which is immediately required to produce purine and thymidylate precursors. This lethal disruption of DNA, RNA, and protein synthesis halts all cellular replication and maintenance functions, resulting in the cessation of proliferation and eventual non-viability of susceptible microbial populations.

Dosage and Administration Information

Administration Scope

Primazol is administered either Orally as a tablet or suspension, or by Intravenous (IV) Infusion for severe use cases. The standard adult dosing regimen for acute infections is typically 800 mg SMX / 160 mg TMP every 12 hours. For serious infections like Pneumocystis pneumonia, a higher, weight-based dose equivalent to 15 to 20 mg/kg/day of the TMP component is used, given in divided doses.

Usage Protocol and Specific Conditions

Treatment duration is dictated by the specific condition, often lasting 5 to 14 days for acute courses, while prophylactic use may be prescribed as once daily or three times per week over longer periods. Oral doses may be taken with or without food but must be accompanied by a full glass of water to ensure adequate fluid intake.

Dose Adjustments and Procedural Constraints

The dosage schedule is dependent on specific physiological conditions; notably, a dose reduction is required for patients with moderate renal impairment (Creatinine Clearance of 15 to 30 mL/min). Pediatric dosing for children over two months of age is calculated strictly by body weight (mg/kg/day). For IV administration, the concentrate must be diluted and then administered as a slow infusion over 60 to 90 minutes; rapid injection is strictly prohibited to ensure proper delivery of the medicine.

Connection to the Overall Use Protocol

The established instructions establish a precise, non-advisory protocol that dictates the route, dose, frequency, and preparatory steps required for the proper administration of the medicine. This structure ensures that the quantity and timing of use strictly follow standardized clinical regimens, defining use for both common and severe clinical scenarios.

Recent Clinical Evidence

Primazol: Recent Clinical Evidence

Overview of Clinical Research

Research studies have evaluated the drug's effect on physiological measures. This research has primarily focused on adults diagnosed with the condition. Primazol's properties as an agent are based on its classification as a derivative of the benzodiazepine class, distinguishing it from older compounds in terms of observed recovery and elimination times, which were the focus of several comparative trials.

Key Findings from Efficacy Trials

Large-scale studies investigated changes in symptom frequency and severity in participants receiving the drug. Study results summarized the changes observed in these factors over periods of 12 to 24 weeks. Evidence regarding the drug's influence on symptom progression beyond the studied duration remains limited.

Small pilot studies focused on changes in acute symptoms. These initial investigations included a limited number of participants and were not designed to evaluate long-term outcomes.

Safety and Tolerability Profile

Research explored the tolerability and reported side effects of the drug during long-term administration. Clinical trials documented that the most frequently reported side effects included headache, nausea, and mild dizziness. Research participants with severe kidney issues were noted to require careful monitoring in studies.

Overall, research is ongoing to evaluate the findings related to the drug’s reported effects and side effects.

Frequently Asked Questions (FAQ)

Common questions about Primazol (FAQ)


Q: What happens if I miss a day of taking Primazol?

A: According to regulatory instructions, if a dose is missed, official instructions typically describe taking the dose as soon as it is remembered. If the next dose is almost due, the typical recommendation is to skip the missed dose and resume the normal schedule. Regulatory advice generally emphasizes not taking two doses at once to make up for a missed dose.


Q: Can I take Primazol at the same time as my daily vitamin?

A: Official information indicates that the medicine is known to interfere with the body's utilization of folate (a B-vitamin). Taking supplements that contain Para-aminobenzoic acid (PABA), which may be an ingredient in some vitamin blends, may reduce the medicine's overall effectiveness.


Q: Are there any specific foods I should avoid while using Primazol?

A: Official product warnings advise that monitoring intake of high-potassium foods is important because one of the medicine's components can increase potassium levels in the blood (hyperkalemia). Furthermore, ensuring adequate fluid intake and limiting excessive caffeine consumption is generally advised to maintain hydration.


Q: Is it necessary to finish the entire course of Primazol, even if I feel better?

A: Official patient information consistently emphasizes the importance of completing the full prescribed treatment course, even when symptoms improve quickly. Stopping early risks leaving the infection untreated and may potentially contribute to the bacteria developing resistance to the medicine.


Q: Why do people sometimes stop taking Primazol?

A: Patients may discontinue the medicine due to the onset of common side effects like nausea, or, rarely, because of more severe documented adverse reactions that affect the blood or skin. Regulatory advice underscores that completing the full prescribed course is generally essential to avoid treatment failure.


Q: Is Primazol known to cause any long-term health issues?

A: Official safety data confirms that while the medicine is generally well-tolerated, prolonged use requires routine monitoring. This monitoring is used to check for potential rare but severe effects on the blood and vital organs, such as the liver or kidneys, which have been documented with prolonged use.


Q: Is Primazol suitable for teenagers?

A: According to official regulatory documentation, the medicine is approved for use in children aged two months and older, which includes the teenage population. Dosing for individuals under adult weight is calculated based on body weight to ensure the appropriate amount is administered.


Q: Does Primazol have any effects on sleep patterns?

A: Official product information indicates that sleep disturbances, such as difficulty sleeping (insomnia), have been reported as a possible adverse effect. This is generally considered a less common effect compared to the more frequently reported side effects.


Q: Can Primazol cause changes in mood or anxiety?

A: The official safety profile notes that, though rare, some changes in mental state have been reported. These have included feelings of sadness, nervousness, or discouragement.


Q: How long does the effect of a single dose of Primazol last?

A: Pharmacological information indicates that the concentration of the active components is cleared from the body with a half-life typically between 10 and 12 hours. This clearance rate forms the basis for the usual schedule of taking the medicine approximately every 12 hours to maintain therapeutic levels.


Q: What should I do if I accidentally take two doses of Primazol too close together?

A: If more medicine is taken than the prescribed amount, official patient leaflets advise seeking guidance from a healthcare professional or pharmacist immediately.


Q: Are there any known interactions between Primazol and herbal supplements?

A: Official documents note that interactions are possible. Certain herbal supplements, such as St. John's wort, may increase the potential for side effects. Additionally, supplements containing PABA (Para-aminobenzoic acid) may cause the medicine to be less effective.


Q: Why is Primazol sometimes described as a 'first-line' treatment?

A: The medicine is categorized as a preferred, or 'first-line,' therapy for specific and severe infections, such as Pneumocystis jirovecii pneumonia (PJP). This classification is based on clinical evidence supporting its effectiveness for those particular diseases.


Q: Is Primazol known to be habit-forming?

A: No, regulatory documents confirm that this medicine is an antibacterial agent and is not a controlled substance. Therefore, it is not known to have any potential for abuse or dependency.


Q: Can I drink coffee or caffeine while taking Primazol?

A: Caffeine is not listed as a direct interacting substance. However, because caffeine can act as a diuretic, regulatory guidance stresses the importance of maintaining adequate fluid intake while using this medicine, making it advisable to limit excessive caffeine consumption.


Q: What is the potential for Primazol to interact with alcohol?

A: Official warnings recommend avoiding alcohol consumption while using this medicine. The combination may cause a reaction that includes symptoms such as flushing, headache, nausea, and a rapid heartbeat.


Q: Are there any restrictions on driving or operating machinery while on Primazol?

A: Official patient information states that certain side effects, like dizziness or convulsions, can potentially impact a patient's ability to drive or operate heavy machinery. Patients are cautioned to understand how the medicine affects them before engaging in these activities.


Q: Does Primazol interact with hormonal birth control?

A: Studies indicate that the medicine may potentially increase the level of the estrogen component in some hormonal contraceptives. However, official reviews suggest that short courses of the medicine are generally not expected to cause adverse effects on contraceptive control.


Q: Is it true that Primazol can cause sensitivity to the sun?

A: Yes, official safety information documents that this medicine may cause increased sensitivity to sunlight, known as photosensitivity. Protective measures, such as avoiding prolonged sun exposure and using sunscreens, are advised while using this medicine.


Q: What is the physical appearance (color, shape) of the Primazol tablet or capsule?

A: According to product labeling, the tablets are typically described as white, elliptical (oval), and often have a score line on one side. They also include specific identification markings printed on the surface.


Q: Are there different strengths of Primazol available?

A: Yes, official regulatory labeling indicates that the medicine is available in two main tablet strengths: a standard strength and a double strength (DS) tablet.


Q: What does 'contraindicated' mean in relation to Primazol?

A: The regulatory term 'contraindicated' means that the medicine is absolutely not permitted for use in a patient who has a particular pre-existing condition or circumstance. This rule is in place because the official assessment has determined the risk of harm in those situations is greater than any potential benefit.


Q: How is Primazol eliminated from the body?

A: Pharmacological data shows that the active ingredients in the medicine are primarily removed from the body through the kidneys. They are then eliminated in the urine.


Q: Do official documents mention any potential for withdrawal effects after stopping Primazol?

A: Official safety documentation does not list any withdrawal symptoms associated with stopping this medicine. This is because it is an antibacterial agent, not a drug that affects the central nervous system.


Q: Why might a doctor switch me from an older drug to Primazol?

A: Clinical information suggests the medicine may be chosen due to its high rate of absorption when taken orally, known as good bioavailability. It may also be considered to have a potentially lower risk of certain severe gut infections compared to some other classes of antibiotics.


Q: Does Primazol affect blood sugar levels?

A: Official safety information indicates the medicine has the potential to affect blood sugar. It can enhance the effect of certain anti-diabetic medications, potentially leading to low blood sugar (hypoglycemia). Rare cases of low blood sugar have also been reported in patients without diabetes.


Q: Are there any specific tests I need before starting Primazol?

A: There is no single mandatory test required for every patient before beginning a short treatment course. However, official guidance requires the doctor to assess any pre-existing conditions, such as severe kidney or liver issues, to determine if the medicine is suitable and if any dose adjustments are needed.


Q: Can I take Primazol if I have a heart condition?

A: General heart conditions are not listed as an absolute prohibition in official documents. However, the medicine can influence electrolyte levels, specifically increasing potassium in the blood, which may lead to an irregular heart rhythm. This potential effect is a key safety consideration.


Q: Why does the packaging of Primazol contain a specific warning about a certain population?

A: Official safety documents mandate specific warnings to draw attention to high-risk patient populations. This includes warnings for populations such as the elderly, who may be more susceptible to adverse effects, and a specific contraindication for infants under two months of age.


Q: What are the characteristics of the typical user of Primazol?

A: The typical user is defined by the medicine's approved uses, or indications. Official documentation states the drug is approved for use in adults and children aged two months and older who have been diagnosed with specific susceptible bacterial infections, such as those affecting the urinary tract, lungs, or ears.

How should Primazol be stored and disposed of?

How to Store and Dispose of Primazol (Co-trimoxazole)

The storage of Primazol must strictly adhere to the conditions mandated in official regulatory labeling to maintain the product's stability as an antibacterial agent.

Official Storage Requirements

Requirement Specific Condition
Temperature Must be stored at Controlled Room Temperature between 20 C and 25 C (68 F and 77 F).
Protection Keep in the original container, tightly closed, and protect from light and moisture; liquid forms must not be frozen.
Safety Keep the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Primazol must be disposed of according to local pharmaceutical waste regulations. Do not flush this medication down the toilet or pour it into a drain unless instructed to do so by an official take-back program. This ensures compliant handling and prevents the medicine from entering the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Primazol found in:

A-Z Index: